Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download Microsoft EdgeDownload Microsoft Edge

Clinically validated software

We work with the NHS to create prescribed digital therapeutics and hospital systems for clinical care.

Clinically validated software

We work with the NHS to create prescribed digital therapeutics and hospital systems for clinical care.

The need for safe remote monitoring during the COVID-19 epidemic

As the need for remote health monitoring intensifies during the COVID-19 epidemic, Sensyne Health are developing and deploying products that enable patient groups to record their health information and be safely managed at home, clinicians to deliver continued contact and care, and healthcare organisations such as the NHS to reduce pressure on their resources.

Data generated from these products contributes to medical research aimed at predicting, diagnosing, treating and preventing a variety of conditions including COVID-19 infection.

Our digital health products

Our products connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research and improving patient outcomes.

Developed in partnership

Our four digital health products (SEND, GDm-Health, EDGE and Support-HF) have been developed in collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust and our product for air pollution monitoring (CleanSpace) has been validated by the National Physical Laboratory.